Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01615172
Other study ID # AXI-001
Secondary ID
Status Recruiting
Phase N/A
First received June 4, 2012
Last updated August 5, 2014
Start date January 2011
Est. completion date December 2014

Study information

Verified date August 2014
Source Johann Wolfgang Goethe University Hospitals
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

Comparision of two different cannulation techniques on the neurological outcome in cardiac surcical procedures. Study hypothesis: Cannulation of the axilaris artery can reduce neurolocical side effects.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 85 Years
Eligibility Inclusion Criteria:

- Cardiac procedure with ecc Age 40-85 years CABG and/or valve

Exclusion Criteria:

- Stenosis of a.subclavia

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
cannulation
The different types of cannulation (aortic versus axillaris) were compared in the postoperative period for neurological deficits in three time periods.(intraoperative, 5.POD, 3 month POD)

Locations

Country Name City State
Germany Goethe Universität Frankfurt Hessen

Sponsors (2)

Lead Sponsor Collaborator
Johann Wolfgang Goethe University Hospitals Pitzer Stiftung

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Surrogat endpoint: Number of participants with change from baseline in Neurolocial events at 5th postoperative day (POD) and 3 month after operation Neurological events were detected by:NIRO (Near-infrared spectroscopy), EEG (Electrencenphalographie), MRI (Magnet resonance imaging) and test battery (Mini mental status test, HAWIE-R) Participants will be followed for the duration of hospital stay (5 POD) and a follow up visit 3 months after discharge Yes
See also
  Status Clinical Trial Phase
Completed NCT04766645 - ACE2 Gender Differences in Stroke With COVID-19
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Completed NCT00070681 - Outcomes of Sleep Disorders in Older Men Phase 3
Terminated NCT00006321 - Neurocognitive Function in Snoring Children N/A
Terminated NCT03270189 - Effect of the Visual Information Change in Functional Dystonia N/A
Completed NCT04422925 - s100β, NSE n GFAP in Living Donor Hepatectomy and Delirium
Suspended NCT04912115 - Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia Phase 2
Completed NCT04568707 - Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES) N/A
Completed NCT02605733 - The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
Recruiting NCT01708668 - The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia N/A
Completed NCT00006424 - Study of Brain Changes Shaped by Experience N/A
Recruiting NCT03749538 - Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies N/A
Not yet recruiting NCT06387290 - Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits N/A
Completed NCT02038491 - RICALOR Italian Registry for Complications During Regional Anesthesia N/A
Completed NCT04260035 - The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients N/A
Terminated NCT03913130 - Extension Study to Study PQ-110-001 (NCT03140969) Phase 1/Phase 2
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Recruiting NCT04855045 - An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. Phase 2/Phase 3
Completed NCT02418286 - KLOS Study - Korean Medicine Registry for Low Back Pain Patients, a Prospective, Observational, Multicenter, Pilot Study
Completed NCT05523076 - Transdiagnostic Markers of Cognitive Symptoms in Disorders Affective.